Chemistry World3d
Ending of US weight-loss drug shortages prompts compounder complaints
Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...
The State of Weight Loss Drugs
How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...
S&P 500 closes higher on soft inflation report, Nasdaq jumps 1% as traders snap up tech shares
Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...
pharmaphorum4d
Lilly’s Mounjaro wins latest head-to-head battle in clinical trials of diabetes treatments
For some patients, injectables, such as insulin ... with Lilly’s once-weekly injectable Trulicity taking on Novo Nordisk’s once-daily injectable Victoza — and the gamble paid off again ...
Investing3d
Adapthealth at Barclays Conference: Strategic Shifts and Modest Growth
Our TAM for CGMs and for insulin pumps that we provide patients ... The reason for that is we’re coming off a full year of our capitated Humana agreement across 33 different states, and so ...
pharmaphorum4d
FDA knocks back Zealand's dasiglucagon once again
In CHI, the beta cells in the pancreas do not function properly and secrete too much insulin ... drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled ...
The Pharma Letter4d
Semaglutide and tirzepatide potential to transform type 1 diabetes treatment
A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...